: WHO: Yale's and UConn's Lies About Immunosuppressive Tb Antigens a Threat to Global Health

[Mort Zuckerman]

To: kathleen...@hhs.gov, francis...@nih.hhs.gov,
margaret...@fda.hhs.gov, dwh...@forbes.com,
ca...@drcarolgoodheart.com, lPick...@cdc.gov, Durlan...@yale.edu,
Aa...@columbia.edu, gary_w...@nymc.edu,
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, margaret...@hhs.fds.gov,
emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@ct.gov, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@ct.gov, kur...@washpost.com, georg...@washpost.com,
p...@allegorypress.com, commissi...@po.state.ct.us,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@ct.gov,
randall...@usdoj.gov, Robert....@yale.edu, editor@greenwich-
post.com, harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, saint....@sbcglobal.net
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, bmi...@newstimes.com, tr...@hotmail.com,
rast...@aol.com, billc...@gmail.com, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org, meganm...@theatlantic.com

Subject: WHO: Yale's and UConn's Lies About Immunosuppressive Tb
Antigens a Threat to Global Health

Date: Sep 14, 2011 9:47 AM

WHO: Dangerous TB Spreading at Alarming Rate in Europe

Read more: http://www.foxnews.com/health/2011/09/14/who-dangerous-tb-spreading-at-alarming-rate-in-europe/#ixzz1Xvs0wlZC

==================================

Yeah, unfortunately no one at Yale or
UConn has come clean yet on the
mechanisms of immunosuppression
via the Tb like antigen, OspA
or LYMErix.

They observed it early on in their
"careers," however:
http://www.actionlyme.org/101016.htm

These crooks are unfunded now.

Worry less.

But you can search for the mechanisms
of immunosuppression by TLR2 agonism here:
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed

or here:
http://projectreporter.nih.gov/reporter.cfm


Said UConn's Justin Radolf:
‎"More recently, we reported that synthetic
lipohexapeptide analogs (lipopeptides) corresponding to
the N termini of the native spirochetal lipoproteins could be
used as lipoprotein surrogates in immune cell activation studies
(16, 37)." - This is on the first page of:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC173182/pdf/631507.pdf

Which means they "ACT LIKE" the real
thing, structure equaling function.


Said Radolf's pal Clifford Harding:

"We propose that Toll-like receptor (TLR) signaling by MTB pathogen-
associated molecular patterns (PAMPs) produces both immune- activating
effects (e.g.induction of pro-inflammatory cytokines by macrophages or
maturation of dendritic cells) and ***late phase downregulatory
effects (e.g.inhibition of MHC-II expression and Ag processing by
macrophages that are chronically infected with MTB)."***
http://projectreporter.nih.gov/project_info_description.cfm?aid=7750609&icde=0

Meaning ^^^ no antibodies are produced
late in the disease (Ag means antigen,
the processing of which results in
antibodies). Like Lyme.

Contrary to the fraudulent Deaborn
diagnostic standard for Lyme, causing
the crooks to hide behind "Guidelines."

Disgusting cowards.


So, since the TLR2 agonist LYMErix
causes immunosuppression via the
inhibition of the auto-kill caspases,
the net result is the same as the
herpesviruses - responsible for
most of the common cancers - which
all allegedly carry homologs of BCL-2
or the human anti-apoptosis gene.

RESULT: Inhibition of the normal destruction
of cells harboring latent viruses gone
unlatent. They can do what they want.
Proceeed.
Do what viruses do.
And do what fungi do - create uneradicable
biofilms.

And do what Staph aureus (TLR2 agonist)does
- which is something Yale and UConn cannot
admit to without self-indicting. MRSA is
the deadliest infectious disease in America
at present, I note.

Yale and UConn can't discuss that.
http://www.ncbi.nlm.nih.gov/pubmed?term=%28%22staphylococcus%20aureus%22[MeSH%20Terms]%20OR%20%28%22staphylococcus%22[All%20Fields]%20AND%20%22aureus%22[All%20Fields]%29%20OR%20%22staphylococcus%20aureus%22[All%20Fields]%20OR%20%28%22staph%22[All%20Fields]%20AND%20%22aureus%22[All%20Fields]%29%20OR%20%22staph%20aureus%22[All%20Fields]%29%20AND%20tlr2[All%20Fields]&cmd=DetailsSearch

They'd have to start talking about why
MRSA is so tough to get rid of.

LOL.





Meanwhile, a peep with Chronic Lyme or
LYMErix Disease or a peep immune suppressed
from RA treatment (TNF inhibitors) could travel
outside the United States - seeking treatment, no
doubt - and what do you get?

A bipedal bioweapons arsenal.

No defense against common viral variants.

No defense against fungi of all kinds.

Remember, only healthy people strongly
react initially to Fungal/Tubercular/Lyme
antigens.

Especially, secondary to influenza.

= = = =

It surprises me not at all the the WHO
is pissed.

We could have learned about this in the
1990s when Yale discovered LYMErix produced
a Chronic Lyme-Like illness:
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm

"If peeps come in with a chronic
Lyme like illness from LYMErix
vaccination, tell them it is
psychiatric..."-- Robert Schoen.

"...And then leave it to the rest of
the world to make the connection
between Yale's terms, "VAGUE" and
"PSYCHIATRIC;" the intelligent ones
among them making the next cognitive leap"

"Hisss hissssssssssssss...."


It's SCIENTIFIC VALID TERMS and
ANALYSES no one wants to approach when
discussing biotech crime and psychiatry."

Reality, that is.


KMDickson
http://www.actionlyme.org


==========================================


Multidrug-resistant and extensively drug-resistant forms of
tuberculosis (TB) are spreading at an alarming rate in Europe and will
kill thousands unless health authorities halt the pandemic, the World
Health Organization(WHO) said on Wednesday.

Launching a new regional plan to find, diagnose and treat cases of the
airborne infectious disease more effectively, the WHO's European
director warned that complacency had allowed a resurgence of TB and
failure to tackle it now would mean huge human and economic costs in
the future.

"TB is an old disease that never went away, and now it is evolving
with a vengeance," said Zsuzsanna Jakab, the WHO's Regional Director
for Europe.

"The numbers are scary," Lucica Ditiu, executive secretary of the Stop
TB Partnership told a news conference in London. "This is a very
dramatic situation."

TB is currently a worldwide pandemic that kills around 1.7 million
people a year. The infection is caused by the bacterium Mycobacterium
tuberculosis and destroys patients' lung tissue, causing them to cough
up the bacteria, which then spreads through the air and can be inhaled
by others.

Cases of multidrug-resistant (MDR-TB) and extensively drug-resistant
TB (XDR-TB) -- where the infections are resistant to first-line and
then second-line antibiotic treatments -- are spreading fast, with
about 440,000 new patients every year around the world.

According to the WHO and Stop TB, 15 of the 27 countries with the
highest burden of MDR-TB are in the WHO's European region, which
includes 53 countries in Europe and Central Asia.

More than 80,000 MDR-TB cases occur in the region each year -- almost
a fifth of the world's total. The WHO said precise figures for XDR-TB
are not available because most countries lack the facilities to
diagnose it, but officially reported cases of XDR-TB increased six-
fold between 2008 and 2009.

Rates are highest in eastern Europe and Central Asia, but many
countries in western Europe have increasing rates of TB and drug-
resistant TB, Ditiu said. Britain's capital, London, has the highest
TB rate of any capital city in western Europe with around 3,500 cases
a year, 2 percent of which are MDR-TB.

Treating even normal TB is a long and unpleasant process, with
patients needing to take a combination of powerful antibiotics for 6
months. Many patients fail to correctly complete the course of
medicines, a factor which has fueled a rise in drug-resistant forms of
the disease.

Treatment regimes for MDR-TB and XDR-TB can stretch into two or more
years, costing up to $16,000 in drugs alone and up to $200,000 to
$300,000 per patient if isolation hospital costs, medical care and
other resources are taken into account.

Experts say around 7 percent of patients with straightforward TB die,
and that death rate rises to around 50 percent of patients with drug-
resistant forms.

The WHO's action plan for tackling tuberculosis emphasizes the need
for doctors and patients to be more aware of the disease and its
symptoms, to diagnose and treat cases promptly with the right drugs,
and follow patients up over many months or years to ensure they take
their medications.

If that doesn't happen "not only are these people quietly and
painfully dying, they are also spreading the disease," Ditiu said.

The WHO said that if the plan is fully implemented -- at an estimated
cost of $5 billion -- 127,000 people will be successfully treated for
drug-resistant TB and 120,000 deaths will be averted by 2015.

The cost would also be recouped, since 250 000 MDR-TB and 13,000 XDR-
TB cases will be prevented, saving $7 billion in averted treatment
costs, the WHO said. It added that prevention of premature deaths
among TB patients would add to economic productivity in the region and
generate an extra $5 billion.

Read more: http://www.foxnews.com/health/2011/09/14/who-dangerous-tb-spreading-at-alarming-rate-in-europe/#ixzz1XvsNE6g3